Please assess the completion status of the following clinical trial:

Trial Title: AKI in Thoracic and Abdominal Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age ≥ 21 (per manufacturer's instructions on the Nephrocheck kit)~* history of hypertension, whether medically treated or untreated~* scheduled for Anesthesia preoperative clinic visit~* scheduled to undergo prolonged intra-abdominal or intra-thoracic surgeries (defined as scheduled intraoperative time ≥ 4h). Intra-abdominal surgeries will include colorectal surgery, massive ventral hernia repairs, hepatobiliary surgery and gynecologic-oncology surgery. Intra-thoracic surgeries will include video-assisted thoracoscopic surgery (VATS)-assisted segmentectomy and lobectomies, as well as mediastinal mass excisions.~* will be anticipated to be admitted to the ICU for a minimum of 2-3 days post-operatively~Exclusion Criteria:~* history of chronic kidney as defined by estimated glomerular filtration rate (GFR) \<90~* patient taking NSAIDs on a daily basis~* patients with a reported allergy or intolerance to NSAIDs

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ketorolac (Type: None): Patients who receive ketorolac perioperatively
- Caldolor (Type: None): Patients who receive Caldolor perioperatively
- No NSAIDS (Type: None): Patients who do not receive NSAIDS perioperatively

Based on this trial design, predict the completion outcome and termination type (if applicable).